Aperio Group LLC lifted its stake in shares of LifePoint Health Inc (NASDAQ:LPNT) by 59.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 72,315 shares of the company’s stock after acquiring an additional 26,892 shares during the period. Aperio Group LLC owned 0.19% of LifePoint Health worth $3,399,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Schwab Charles Investment Management Inc. raised its holdings in shares of LifePoint Health by 1.4% during the 1st quarter. Schwab Charles Investment Management Inc. now owns 171,904 shares of the company’s stock worth $8,080,000 after acquiring an additional 2,361 shares during the period. Chicago Equity Partners LLC purchased a new stake in LifePoint Health in the 1st quarter valued at about $953,000. Quantitative Systematic Strategies LLC purchased a new stake in LifePoint Health in the 1st quarter valued at about $418,000. LSV Asset Management raised its holdings in LifePoint Health by 6.6% in the 1st quarter. LSV Asset Management now owns 2,246,057 shares of the company’s stock valued at $105,564,000 after buying an additional 138,600 shares during the period. Finally, Swiss National Bank raised its holdings in LifePoint Health by 3.3% in the 1st quarter. Swiss National Bank now owns 69,800 shares of the company’s stock valued at $3,281,000 after buying an additional 2,200 shares during the period.
LifePoint Health traded down $0.05, reaching $54.80, on Thursday, according to MarketBeat Ratings. The company’s stock had a trading volume of 356,200 shares, compared to its average volume of 504,285. The company has a quick ratio of 1.55, a current ratio of 1.76 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $2.16 billion, a price-to-earnings ratio of 15.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.51. LifePoint Health Inc has a fifty-two week low of $41.45 and a fifty-two week high of $67.95.
Several brokerages recently issued reports on LPNT. Mizuho restated a “hold” rating and issued a $51.00 price objective on shares of LifePoint Health in a report on Thursday, March 22nd. Robert W. Baird restated a “buy” rating and issued a $54.00 price objective on shares of LifePoint Health in a report on Tuesday, March 27th. Wolfe Research upgraded shares of LifePoint Health from an “underperform” rating to a “peer perform” rating in a report on Friday, March 16th. Royal Bank of Canada cut their price target on shares of LifePoint Health to $58.00 and set an “outperform” rating on the stock in a research note on Monday, February 26th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $46.00 price target (down from $50.00) on shares of LifePoint Health in a research note on Monday, February 26th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $54.87.
LifePoint Health Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.